Quinn Opportunity Partners LLC grew its position in Centene Corporation (NYSE:CNC – Free Report) by 64.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,981 shares of the company’s stock after acquiring an additional 59,000 shares during the period. Quinn Opportunity Partners LLC’s holdings in Centene were worth $5,387,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of CNC. Vanguard Group Inc. lifted its stake in Centene by 1.5% in the 2nd quarter. Vanguard Group Inc. now owns 58,396,605 shares of the company’s stock valued at $3,169,768,000 after purchasing an additional 869,706 shares during the last quarter. Norges Bank acquired a new position in Centene during the second quarter worth approximately $1,435,997,000. State Street Corp lifted its position in shares of Centene by 2.3% in the second quarter. State Street Corp now owns 23,186,927 shares of the company’s stock valued at $1,258,586,000 after buying an additional 514,600 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Centene by 2.2% in the second quarter. Geode Capital Management LLC now owns 13,208,639 shares of the company’s stock valued at $718,547,000 after buying an additional 279,637 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in shares of Centene by 5.7% during the 2nd quarter. Invesco Ltd. now owns 11,725,910 shares of the company’s stock worth $636,482,000 after acquiring an additional 633,946 shares during the period. 93.63% of the stock is owned by institutional investors.
Centene Price Performance
Centene stock opened at $34.47 on Friday. The stock’s fifty day moving average price is $42.81 and its two-hundred day moving average price is $38.33. The firm has a market cap of $16.95 billion, a PE ratio of -2.53, a price-to-earnings-growth ratio of 0.77 and a beta of 0.48. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.10 and a quick ratio of 1.10. Centene Corporation has a one year low of $25.08 and a one year high of $66.03.
Analysts Set New Price Targets
CNC has been the topic of a number of research analyst reports. TD Cowen increased their price target on Centene from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Wednesday, February 11th. Cantor Fitzgerald reiterated a “neutral” rating and issued a $41.00 price objective on shares of Centene in a report on Monday, February 9th. JPMorgan Chase & Co. increased their price objective on shares of Centene from $38.00 to $45.00 and gave the company a “neutral” rating in a research report on Thursday, January 22nd. Argus raised shares of Centene to a “hold” rating in a report on Monday, February 9th. Finally, Truist Financial upped their price target on shares of Centene from $47.00 to $49.00 and gave the company a “buy” rating in a research note on Wednesday, February 25th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $42.06.
Check Out Our Latest Stock Analysis on Centene
Centene Company Profile
Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.
Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.
Featured Stories
- Five stocks we like better than Centene
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- Iran isn’t the real war
- This coin has everything going for it
- Only 500 people today…
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.
